TE_110
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2d_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | MTOR |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 0.85 |
| Counts of samples | TCGA_tumor:1983; TCGA_normal:106; GTEx:2525 |
| TSS | chr1(-):11111663 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_110.1 | MTOR | Annoated | Non-coding | Non-coding | chr1(-):11107480,11107500,11108181,11108286,11109290,11109370,11109649,11109729,11111514,11111664 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
